Exhibit 31.2

                                 CERTIFICATIONS
                    required by Rules 13a-14(a) or 15d-14(a)

I, Linden Boyne, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Bioaccelerate
Holdings, Inc., the issuer;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the issuer as of,
and for, the periods presented in this report;

4. The issuer's other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:

      a.    Designed such disclosure controls and procedures, or caused such
            disclosure controls and procedures to be designed under our
            supervision, to ensure that material information relating to the
            issuer, including its consolidated subsidiaries, is made known to us
            by others within those entities, particularly during the period in
            which this report is being prepared;

      b.    Designed such internal control over financial reporting, or caused
            such internal control over financial reporting to be designed under
            our supervision, to provide reasonable assurance regarding the
            reliability of financial reporting and the preparation of financial
            statements for external purposes in accordance with generally
            accepted accounting principles;

      c.    Evaluated the effectiveness of the issuer's disclosure controls and
            procedures and presented in this report our conclusions about the
            effectiveness of the disclosure controls and procedures, as of the
            end of the period covered by this report based on such evaluation;
            and

      d.    Disclosed in this report any change in the issuer's internal control
            over financial reporting that occurred during the issuer's most
            recent fiscal quarter (the issuer's fourth fiscal quarter in the
            case of an annual report) that has materially affected, or is
            reasonably likely to materially affect, the issuer's internal
            control over financial reporting; and

5. The issuer's other certifying officers and I have disclosed, based on our
most recent evaluation, to the issuer's auditors and the audit committee of the
issuer's board of directors (or persons performing the equivalent functions):

      a.    All significant deficiencies and material weaknesses in the design
            or operation of internal control over financial reporting which are
            reasonably likely to adversely affect the issuer's ability to
            record, process, summarize and report financial information; and

      b.    Any fraud, whether or not material, that involves management or
            other employees who have a significant role in the issuer's internal
            control over financial reporting.

Date: November 17, 2004        By: /s/ Linden Boyne
                                   ---------------------------------------------
                                   Linden Boyne, Secretary-Treasurer & Director
                                   (Chief Financial Officer)